OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression
Abstract Recent data indicate that receptor for activated C kinase 1 (RACK1) is a putative prognostic marker and drug target in breast cancer (BC). High RACK1 expression is negatively associated with overall survival, as it seems to promote BC progression. In tumors, RACK1 expression is controlled b...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-12-01
|
Series: | Oncogenesis |
Online Access: | https://doi.org/10.1038/s41389-020-00291-x |